Delivra Health Brands Inc
Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancou… Read more
Market Cap & Net Worth: Delivra Health Brands Inc (DHBUF)
Delivra Health Brands Inc (OTCQB:DHBUF) has a market capitalization of $3.86 Million ($3.86 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #33111 globally and #10832 in its home market, demonstrating a -5.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Delivra Health Brands Inc's stock price $0.12 by its total outstanding shares 31261781 (31.26 Million).
Delivra Health Brands Inc Market Cap History: 2022 to 2025
Delivra Health Brands Inc's market capitalization history from 2022 to 2025. Data shows growth from $487.68K to $3.86 Million (97.51% CAGR).
Delivra Health Brands Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Delivra Health Brands Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Delivra Health Brands Inc's market cap is 0.03 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.43x
Delivra Health Brands Inc's market cap is 0.43 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $487.68K | $8.14 Million | -$7.01 Million | 0.06x | N/A |
| 2023 | $525.20K | $9.79 Million | -$184.00K | 0.05x | N/A |
| 2024 | $375.14K | $12.38 Million | $876.00K | 0.03x | 0.43x |
Competitor Companies of DHBUF by Market Capitalization
Companies near Delivra Health Brands Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Delivra Health Brands Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Delivra Health Brands Inc Historical Marketcap From 2022 to 2025
Between 2022 and today, Delivra Health Brands Inc's market cap moved from $487.68K to $ 3.86 Million, with a yearly change of 97.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.86 Million | +929.17% |
| 2024 | $375.14K | -28.57% |
| 2023 | $525.20K | +7.69% |
| 2022 | $487.68K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Delivra Health Brands Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.86 Million USD |
| MoneyControl | $3.86 Million USD |
| MarketWatch | $3.86 Million USD |
| marketcap.company | $3.86 Million USD |
| Reuters | $3.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.